The prevalence and cost of unapproved uses of top-selling orphan drugs (Q21134770)
Jump to navigation
Jump to search
scientific article
- The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The prevalence and cost of unapproved uses of top-selling orphan drugs |
scientific article |
|
Statements
The prevalence and cost of unapproved uses of top-selling orphan drugs (English)
0 references
Aaron S Kesselheim
Aaron S
Kesselheim
1 reference
Wolfgang C Winkelmayer
Wolfgang C
Winkelmayer
1 reference
1 reference
Daniel H Solomon
Daniel H
Solomon
1 reference
Jessica A Myers
1 reference
Raisa Levin
1 reference
2012
0 references
7
0 references
2
0 references
e31894
0 references
21 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference